Wisewill Intergenix Neuro Neutirlisation System Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 1 Year 1 Month
About Wisewill Intergenix Neuro Neutirlisation System
Wisewill Intergenix Neuro Neutirlisation System Private Limited (WINNSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2023 (One year and one month 11 days old ). Its registered office is in Delhi, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Chaturvedi, Jitender, and Bhawna serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47890DL2023PTC424624
-
Company No.
424624
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Dec 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Who are the key members and board of directors at Wisewill Intergenix Neuro Neutirlisation System?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Chaturvedi
|
Director | 30-Dec-2023 | Current |
|
Jitender
|
Director | 30-Dec-2023 | Current |
|
Bhawna
|
Director | 30-Dec-2023 | Current |
Financial Performance of Wisewill Intergenix Neuro Neutirlisation System.
Enhance accessibility to Wisewill Intergenix Neuro Neutirlisation System's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wisewill Intergenix Neuro Neutirlisation System?
Unlock access to Wisewill Intergenix Neuro Neutirlisation System's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gautam Buddha Jan Seva FoundationSachin Chaturvedi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wisewill Intergenix Neuro Neutirlisation System?
Unlock and access historical data on people associated with Wisewill Intergenix Neuro Neutirlisation System, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wisewill Intergenix Neuro Neutirlisation System, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wisewill Intergenix Neuro Neutirlisation System's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.